Daclatasvir dihydrochloride

Daclatasvir is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has yet to be convincingly implicated in cases of clinically apparent liver injury with jaundice.

Price Not Available 25 mg Daclatasvir dihydrochloride Supplier Page

Catalog Number	T1786
Alternative Name(s)	BMS-790052 dihydrochloride
Research Area	Proteases/Proteasome\|\|\|Microbiology/Virology
Molecular Formula	C40H52Cl2N8O6
CAS#	1009119-65-6
Purity	99.84%
SMILES	O=C(N1[C@H](c2[nH]c(cn2)c2ccc(c3ccc(c4[nH]c(nc4)[C@H]4N(C(=O)[C@@H](NC(=O)OC)C(C)C)CCC4)cc3)cc2)CCC1)[C@@H](NC(=O)OC)C(C)C.Cl.Cl
Size	25 mg
Supplier Page	https://www.targetmol.com/compound/Daclatasvir dihydrochloride
Additional Information	https://www.targetmol.com/datasheet/T1786